NEW YORK – Genetic diagnostics company NIPD Genetics of Cyprus has launched a number of cancer genetic tests, a new area for the firm, while expanding its existing business by adding a new prenatal genetic screening test to its menu.
In addition to offering genetic testing services from its CLIA-certified and CAP-accredited laboratory in 24 countries, primarily in Eastern Europe, the Middle East, North Africa, and Asia, the firm also recently started a technology transfer program, allowing partners to bring its proprietary test technology in house.